Want to track ABT and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Abbott Laboratories (ABT) Statistics
Valuation metrics
Market Cap -
Enterprise value 202.59B
Trailing P/E (ttm) 27.96
Forward P/E -
PEG ratio -0.46
Price/Sales (ttm) 3.89
Price/Book (mrq) 3.38
Enterprise Value/Revenue 4.35
Enterprise Value/EBITDA 20.38
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 1
Average volume (90 days) -
Price summary
52-Week low 65
52-Week high 106
Beta -
50-Day moving average 73.46
200-Day moving average 81.37
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate 2.48
Trailing annual dividend yield 0.0246%
5-Year annual dividend yield -
Payout ratio 0.67
Dividend Date 15 May 2026
Ex-Dividend Date 15 Apr 2026
Last split factor 2:1
Last split Date 3 Jan 2013
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 0.14%
Operating margin 0.18%
Operational effectiveness
Return on assets 0.05%
Return on equity 0.11%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 25.84
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 3.59
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 4.18
Total debt (mrq) -
Total Debt/Equity (mrq) 0.65
Current ratio (mrq) 1.39%
Book value per share (mrq) 30.17
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
